logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • CMP Pharma, Inc. drugs

    FiltersReset Filters
    9 results

    • atorvaliq

      (ATORVALIQ)
      CMP Pharma, Inc.
      Usage: ATORVALIQ is indicated to reduce the risk of cardiovascular events in adults with risk factors for coronary heart disease, type 2 diabetes, and clinically evident coronary heart disease. It also lowers LDL cholesterol in various conditions, including primary hyperlipidemia and familial hypercholesterolemia, as an adjunct to diet or other therapies.

    • carospir

      (CaroSpir)
      CMP Pharma, Inc.
      Usage: CAROSPIR is indicated for treating NYHA Class III-IV heart failure and reduced ejection fraction in adults to improve survival and reduce hospitalization. It also serves as an add-on therapy for hypertension management and is used for managing edema in cirrhotic patients unresponsive to fluid or sodium restriction.

    • isoniazid - isoniazid solution

      (Isoniazid)
      Cmp Pharma, Inc.

    • norliqva

      (amlodipine)
      CMP Pharma, Inc.
      Usage: NORLIQVA® is indicated for treating hypertension in adults and children ages 6 and older, reducing cardiovascular event risk. It also treats chronic stable angina, vasospastic angina, and helps patients with angiographically documented coronary artery disease to lower hospitalization and revascularization risks. It can be used alone or with other agents.

    • potassium phosphates - monobasic potassium phosphate and dibasic potassium phosphate injection

      (Monobasic Potassium Phosphate And Dibasic Potassium Phosphate)
      Cmp Pharma, Inc.

    • sodium polystyrene sulfonate - sodium polystyrene sulfonate powder, for suspension

      (Sodium Polystyrene Sulfonate)
      Cmp Pharma, Inc.

    • sodium polystyrene sulfonate - sodium polystyrene sulfonate suspension

      (Sodium Polystyrene Sulfonate)
      Cmp Pharma, Inc.

    • tadliq

      (Tadalafil)
      CMP Pharma, Inc.
      Usage: TADLIQ® is indicated for treating pulmonary arterial hypertension (PAH) in patients to improve exercise ability, particularly those with NYHA Functional Class II-III symptoms due to idiopathic or heritable PAH or PAH associated with connective tissue diseases.

    • triamcinolone acetonide - triamcinolone acetonide ointment

      (Triamcinolone Acetonide)
      Cmp Pharma, Inc.